Inherited mutations in the gene BRCA2 significantly increase the risk of carriers to breast and ovarian cancers. BRCA2, a crucial player in the body's DNA repair system, aids in repairing damaged DNA.
Real-world treatment patterns and outcomes of zanubrutinib in chronic lymphocytic leukemia and small lymphocytic leukemia (CLL/SLL). This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting ...
The field of cancer research has increasingly focused on the metabolic underpinnings of tumorigenesis, recognizing how the reprogramming of cellular energy ...
SCOTTSDALE, Ariz. — Feb. 18, 2025 — Sunil Sharma, M.D., MBA, one of the nation’s leading experts in creating anti-cancer drugs, has been named director of HonorHealth Research Institute’s new Center ...
The Horner–Wadsworth–Emmons (HWE) reaction is a fundamental reaction in organic chemistry, widely used to create conjugated carbonyl compounds. Conjugated carbonyl compounds are used in many ...
“My appointment to serve on the NIH Drug Discovery and Molecular Pharmacology Study Section is an immense honor and a significant milestone in my career,” says Woo. “It signifies recognition of my ...
(Top) Melanoma develops resistance to BRAF inhibitors, leading to cancer recurrence. (Bottom) By combining polyamine biosynthesis inhibition with BRAF inhibitors, the recurrence of cancer can be ...
The University of Warwick and Sun Yat-sen University Cancer Center have signed a Memorandum of Understanding (MoU) to create a research partnership in cancer diagnosis and specialist cancer care. The ...
The National Institutes of Health (NIH) Center for Scientific Review has appointed Sukyung Woo, PhD, associate professor, Department of Pharmaceutical Sciences, to serve as a member of its Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results